U.S. health officials have approved a medication related to the mind-altering drug ketamine as a new option for patients with severe depression.
Health
Maine companies send workers to Boston for health care at ‘fraction of the cost’
Competition among metro-area hospitals pulls prices down, but the outsourcing of patients leads to higher costs in Maine.
Across Maine, prices for the same medical procedures are often staggeringly different
Low patient volumes and scarce competition among providers help make the state one of the most costly for health care in the U.S.
Wendy Williams returns to daytime March 4
The talk show host is taking a break following complications from Graves’ disease.
White House ends talks on mileage standards with California, opening door to court battle
President Trump has challenged the state’s practice of setting its own rules, which it has done since the 1970s.
Bill would require all Maine schools to test for lead in drinking water
Schools with well water now must test for the harmful metal, but those on public water don’t have to test.
Treatment of opioid crisis in central Maine gets a boost
While MaineGeneral Health and others have established effective programs to combat the epidemic, health care leaders see new hope in the approaches from Mills’ administration.
Drug company used rap video to push for higher doses, sales
The video, titled “Great by Choice,” was shown during a national sales meeting in 2015 to encourage employees to talk doctors into prescribing higher doses, prosecutors said.
Researchers find clues that depression may speed brain aging
Depression has long been linked to certain cognitive problems, and depression late in life even may be a risk factor for the development of Alzheimer’s.
Measles making comeback on widening anti-vaccine movement
‘Vaccine hesitancy,’ despite evidence refuting a 1998 claim that linked the measles, mumps and rubella vaccine to autism, is slowing attempts to stop children from dying from preventable diseases.